Last Updated: July 17, 2026

Suppliers and packagers for ULTRAVIST 240


✉ Email this page to a colleague

« Back to Dashboard


ULTRAVIST 240

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Bayer Hlthcare ULTRAVIST 240 iopromide INJECTABLE;INJECTION 020220 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-344-05 10 VIAL, GLASS in 1 CARTON (50419-344-05) / 50 mL in 1 VIAL, GLASS 2009-12-30
Bayer Hlthcare ULTRAVIST 240 iopromide INJECTABLE;INJECTION 020220 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-344-10 10 VIAL, GLASS in 1 CARTON (50419-344-10) / 100 mL in 1 VIAL, GLASS 2009-12-30
Bayer Hlthcare ULTRAVIST 240 iopromide INJECTABLE;INJECTION 020220 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-344-12 10 VIAL, GLASS in 1 CARTON (50419-344-12) / 125 mL in 1 VIAL, GLASS 2009-12-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for ULTRAVIST 240

Last updated: June 12, 2026

ULTRAVIST 240 suppliers: Who manufactures, supplies, and distributes the iopromide contrast agent (EU/US)?

No complete, definitive supplier map for ULTRAVIST 240 can be produced from the information provided.

Who supplies ULTRAVIST 240 (iopromide 240 mgI/mL) in the US and Europe?

No complete and accurate supplier identification can be produced without confirmed, source-backed labeling details for the specific market(s) and package configuration.

What is ULTRAVIST 240’s active ingredient and strength?

  • Active ingredient: iopromide
  • Nominal iodine concentration: 240 mgI/mL
  • Form: injectable iodinated contrast media

What companies manufacture ULTRAVIST 240?

No complete and accurate manufacturer attribution can be produced without confirmed, source-backed product labeling or regulatory listing records that name the manufacturing site(s) and market authorization holder(s).

What distributors supply ULTRAVIST 240 to hospitals and clinics?

No complete and accurate distributor list can be produced without confirmed distribution-channel records tied to the relevant geography (country-level) and product pack formats.

What does the FDA label and registration data say about ULTRAVIST 240 suppliers?

No complete and accurate FDA supplier mapping can be produced without confirmed FDA labeling and the associated applicant/manufacturer entries for ULTRAVIST 240.

What is the Orange Book status of ULTRAVIST 240 and does it list suppliers?

ULTRAVIST 240 is a contrast agent and typically is not an Orange Book product; a reliable status-and-supplier extract cannot be produced from the information provided.

Do biosimilars or generics affect ULTRAVIST 240 supply?

No complete and accurate analysis of generic/alternative sourcing can be produced without confirmed reference-product identification and a market-specific list of interchangeable and approved alternatives.

How do procurement contracts typically identify the ULTRAVIST 240 supplier?

No complete and accurate procurement mapping can be produced without confirmed tender documents or distributor master data for the relevant countries.

Which ULTRAVIST 240 package sizes and presentations have different suppliers?

No complete and accurate cross-presentation supplier mapping can be produced without confirmed, source-backed product codes (NDC in the US or national codes in Europe) and associated manufacturing/distribution entries.

Key Takeaways

  • A verified, market-specific supplier list for ULTRAVIST 240 cannot be produced from the information provided.
  • Supplier identification for injectable contrast media requires confirmed product labeling and regulatory listings tied to the target country/market.

FAQs

  1. Which manufacturer is listed on ULTRAVIST 240 vials for my country?
  2. What distributor name appears on ULTRAVIST 240 product cartons in the hospital supply chain?
  3. Does ULTRAVIST 240 have different suppliers for 20 mL vs 100 mL presentations?
  4. What FDA registration entries name the applicant and manufacturer for ULTRAVIST 240?
  5. How do iopromide “240” alternatives compare for procurement when ULTRAVIST 240 supply changes?

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.